Popular Trials
Behavioral Intervention
Collaborative Care for Post-Traumatic Epilepsy
This trial is testing whether regular phone calls from a healthcare team can improve the quality of life for adults with post-traumatic epilepsy and anxiety or depression. The study will observe the effects over several months.
NMDA Receptor Antagonist
IV Ketamine for Epilepsy
This trial is testing small doses of ketamine to help people with epilepsy who don't respond to regular medications. Ketamine can help calm the brain and reduce seizures. The study will monitor patients' seizure activity and mood over time. Ketamine has been used in various settings for its ability to reduce seizures.
Popular Filters
Trials for Temporal Lobe Epilepsy Patients
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Trials for Lennox Gastaut Syndrome Patients
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Phase 3 Trials
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Cenobamate for Epilepsy
This trial aims to ensure the safety of cenobamate, a seizure control medication, for patients who have already participated in a previous study. Cenobamate helps by calming overactive brain signals that cause seizures. Cenobamate is a new medication approved by the FDA in 2019 for the treatment of focal-onset seizures in adults.
Antiepileptic Drug
Brivaracetam for Absence Epilepsy
This trial is testing if the drug brivaracetam, used alone, is safe and effective for children and young adults aged 2 to 25 with certain types of epilepsy. The drug works by helping to control brain activity to prevent seizures.
Cannabidiol for Seizures
This trial tests a medication called GWP42003-P in children under 2 years old who have severe seizure disorders like TSC, LGS, or DS. The study will last over a year and will check if the medication is safe, how it moves through the body, and if it helps reduce seizures. These conditions often don't respond well to usual treatments, so new options are needed. Cannabidiol (pharmaceutical) is approved by the FDA for the treatment of seizures associated with DS, Lennox-Gastaut syndrome, and tuberous sclerosis complex in patients ≥1 year of age.
Trials With No Placebo
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
AMPA Receptor Antagonist
Perampanel for Pediatric Epilepsy
This trial will study the effects of perampanel on seizure frequency in children with epileptic syndrome and partial-onset seizures. They will measure the 50% responder rate during the maintenance period of the study.
Cenobamate for Epilepsy
This trial aims to ensure the safety of cenobamate, a seizure control medication, for patients who have already participated in a previous study. Cenobamate helps by calming overactive brain signals that cause seizures. Cenobamate is a new medication approved by the FDA in 2019 for the treatment of focal-onset seizures in adults.
View More Related Trials
Frequently Asked Questions
Introduction to
What are the top hospitals conducting undefined research?
When it comes to cutting-edge clinical trials in the field of undefined, several hospitals are leading the way. The renowned Mayo Clinic in Rochester is at the forefront, currently conducting an impressive 14 active trials focused on this condition. Although they have yet to conduct any previous undefined trials, their commitment to research and innovation promises exciting developments in the future. In Bethesda, Maryland, the Mid-Atlantic Epilepsy and Sleep Center has also dedicated itself to advancing knowledge in this area with nine ongoing clinical trials. Similarly, the Northeast Regional Epilepsy Group in Hackensack is actively involved in eight undefined trials, each contributing valuable insights.
On another coast altogether lies Seattle Children's Hospital, where experts are immersed in seven active undefined trials aimed at improving our understanding of this complex condition that affects so many lives. Meanwhile,the Children's Hospital of Philadelphia joins these esteemed institutions with an equal number of ongoing undefined studies and a shared mission to push boundaries for better treatments.
These hospitals represent just a fraction of the efforts being made across various locations to unravel the mysteries surroundingundefined.. Through rigorous research and collaboration between medical professionals and patients alike,various strategies can be implementedto address,, manage or even prevent complications associated with such conditions . With every new trial conducted by these dedicated institutions,the potential for transformative breakthroughs grows closer,and hope shines brighter for those affected byundefinedacross different communities nationwide
Which are the best cities for undefined clinical trials?
When it comes to undefined clinical trials, several cities are at the forefront of research and innovation. New york, with its 27 active trials, explores treatments like Lorcaserin, Soticlestat, and ZX008 (Fenfluramine Hydrochloride). Rochester in Minnesota follows closely behind with 22 ongoing studies focused on Ganaxalone (GNX), LP352, and ZX008 (Fenfluramine Hydrochloride). Additionally, Miami in Florida and Philadelphia in Pennsylvania both offer promising opportunities for clinical trials with 21 active studies each. These cities provide individuals seeking cutting-edge medical advancements access to a range of innovative therapies that can potentially transform lives.
Which are the top treatments for undefined being explored in clinical trials?
Clinical trials are actively investigating several promising treatments for an undefined condition. Leading the pack is daratumumab, with an impressive track record of 6 active trials and a total of 134 breast cancer trials since its introduction in 2012. Another noteworthy contender is belantamab mafodotin, currently being explored in 4 ongoing clinical trials with a previous involvement in 26 breast cancer studies since its debut in 2018. Lastly, lenalidomide continues to prove its worth with three active clinical trials and an extensive history of participation in 280 diverse trial settings dating back to 2003. These advancements bring renewed hope as researchers strive to unravel new treatment possibilities for this yet-to-be-defined condition.
What are the most recent clinical trials for undefined?
Recent clinical trials have brought forth promising advancements in the field of undefined conditions, offering potential breakthroughs for patients seeking effective treatments. One such trial investigated the use of fenfluramine as a treatment option, showing positive results during its Phase 2 stage. Additionally, Magnetic Resonance Imaging-guided Focused ultrasound Ablation (MRgFUSA) has shown promise in early-stage testing for undefined conditions. Another study explored the effectiveness of methylphenidate during its Phase 4 trial, providing valuable insights into potential therapeutic benefits. Furthermore, XEN1101 displayed promising outcomes in Phase 3 trials and offers hope for alleviating symptoms associated with undefined conditions. Lastly, Diazepam showcased encouraging results across both Phase 1 and Phase 2 trials conducted earlier this year. As these recent clinical trials continue to unfold and progress towards completion, they hold great potential to enhance the quality of life for individuals living with undefined conditions.
What undefined clinical trials were recently completed?
Recently completed clinical trials in an unspecified field have made significant strides towards advancing medical research. These trials, which concluded within the last year, have contributed valuable insights and potential breakthroughs that hold promise for future treatments. The completion of these trials underscores the dedication and innovation of researchers who are committed to pushing the boundaries of scientific knowledge and improving patient outcomes.